The rat model market size has grown strongly in recent years. It will grow from $1.75 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to expansion of biomedical research activities, increasing use of animal models in drug discovery, growth in academic research institutions, availability of inbred and outbred rat strains, rising toxicology testing requirements.
The rat model market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing investment in precision medicine research, rising demand for predictive disease models, expansion of gene-editing applications, growing focus on reducing clinical trial failure rates, increasing adoption of humanized rat platforms. Major trends in the forecast period include increasing use of crispr-based rat models, rising demand for immunodeficient and humanized rats, growing adoption of preclinical disease modeling, expansion of genetic editing technologies, enhanced focus on translational research accuracy.
The growing demand for medicines is expected to drive the rat model market's growth in the near future. Rat models facilitate research on various medications, as they are easier to feed and smaller than more complex mammals like primates, making them a more convenient option. Consequently, the increase in medicine demand boosts the need for rat models. For instance, in July 2024, the National Center for Biotechnology Information, a US-based government agency, reported that total medicine spending in the United States rose by 13.6% in 2023 compared to 2022, reaching $722.5 billion. Therefore, the rising demand for medicines is propelling the growth of the rat model market.
Major companies and preclinical research organizations are focusing on developing specialized nephropathy animal models to more accurately replicate human kidney diseases and accelerate therapeutic development. Nephropathy animal models are animals engineered or induced to simulate human kidney conditions, enabling researchers to study disease mechanisms, evaluate treatments, and investigate renal dysfunction in a controlled environment. For instance, in October 2024, Physiogenex, a France-based preclinical research company, introduced its new IgA nephropathy rat model at ASN Kidney Week. This model is designed to provide a reliable platform for translational studies, exhibiting key features of IgA nephropathy, including mesangial IgA deposition and proteinuria, thereby supporting the development of targeted therapies and advancing mechanistic research in kidney disease.
In November 2023, Scantox A/S, a Denmark-based company focused on preclinical pharmacology, acquired QPS Austria GmbH for an undisclosed sum. This acquisition is intended to strengthen Scantox A/S's capabilities in drug discovery, particularly in the fields of neurodegenerative diseases, rare diseases, and mental disorders. QPS Austria GmbH, based in Austria, specializes in contract research services for rat models.
Major companies operating in the rat model market are Genoway SA, Charles River Laboratories International Inc, Taconic Biosciences Inc, Envigo Ltd, Janvier Labs, Harlan Laboratories Inc, Cyagen Biosciences Inc, Ozgene Pty Ltd, Beijing Biocytogen Co Ltd, Ingenious Targeting Laboratory, Mirimus Inc, Pharmaron Beijing Co Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Transgenic Inc, Viva Biotech Holdings, WuXi AppTec Co Ltd, Applied StemCell Inc, Transviragen Inc, Biomere, Laboratory Corporation of America Holdings, Horizon Discovery Group PLC, Synthego Corporation, ViGene Biosciences Inc.
North America was the largest region in the rat model market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rat model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the rat model market by increasing costs of imported genetic engineering tools, laboratory consumables, cryopreservation equipment, and specialized breeding materials. Research institutions in North America and Europe are most affected due to reliance on imported reagents and technologies, while Asia-Pacific faces higher costs in model export and collaboration. These tariffs are increasing research expenses and project timelines. However, they are also encouraging regional breeding facilities, local genetic testing capabilities, and domestic development of customized rat models.
The rat model market research report is one of a series of new reports that provides rat model market statistics, including rat model industry global market size, regional shares, competitors with a rat model market share, detailed rat model market segments, market trends and opportunities, and any further data you may need to thrive in the rat model industry. This rat model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The utilization of rat models involves leveraging rat functional genes, cells, tissues, and organs to simulate both healthy and pathological conditions of the human immune system. Humanized rat models play a crucial role in preclinical research, offering a means to replicate human disease states, assess the efficacy of compounds, and analyze their impact on human proteins.
Various types of rat models are available, including knockout, outbred, inbred, hybrid, immunodeficient, and conditioned models. In the context of knockout models, scientists modify or replace a gene to deactivate it, providing a valuable tool for studying the effects of specific gene alterations. Services provided encompass cryopreservation, breeding, re-derivation, genetic testing, and quarantine, utilizing technologies such as nuclear transferase, microinjection, and embryonic stem cells. These services cater to a range of applications, including oncology, neurology, immunology, toxicology, and more.
The rat model market includes revenues earned by entities by providing services such as DNA preparation, genotyping services, knock-in, or transgenic rat or mouse model creation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The rat model market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing investment in precision medicine research, rising demand for predictive disease models, expansion of gene-editing applications, growing focus on reducing clinical trial failure rates, increasing adoption of humanized rat platforms. Major trends in the forecast period include increasing use of crispr-based rat models, rising demand for immunodeficient and humanized rats, growing adoption of preclinical disease modeling, expansion of genetic editing technologies, enhanced focus on translational research accuracy.
The growing demand for medicines is expected to drive the rat model market's growth in the near future. Rat models facilitate research on various medications, as they are easier to feed and smaller than more complex mammals like primates, making them a more convenient option. Consequently, the increase in medicine demand boosts the need for rat models. For instance, in July 2024, the National Center for Biotechnology Information, a US-based government agency, reported that total medicine spending in the United States rose by 13.6% in 2023 compared to 2022, reaching $722.5 billion. Therefore, the rising demand for medicines is propelling the growth of the rat model market.
Major companies and preclinical research organizations are focusing on developing specialized nephropathy animal models to more accurately replicate human kidney diseases and accelerate therapeutic development. Nephropathy animal models are animals engineered or induced to simulate human kidney conditions, enabling researchers to study disease mechanisms, evaluate treatments, and investigate renal dysfunction in a controlled environment. For instance, in October 2024, Physiogenex, a France-based preclinical research company, introduced its new IgA nephropathy rat model at ASN Kidney Week. This model is designed to provide a reliable platform for translational studies, exhibiting key features of IgA nephropathy, including mesangial IgA deposition and proteinuria, thereby supporting the development of targeted therapies and advancing mechanistic research in kidney disease.
In November 2023, Scantox A/S, a Denmark-based company focused on preclinical pharmacology, acquired QPS Austria GmbH for an undisclosed sum. This acquisition is intended to strengthen Scantox A/S's capabilities in drug discovery, particularly in the fields of neurodegenerative diseases, rare diseases, and mental disorders. QPS Austria GmbH, based in Austria, specializes in contract research services for rat models.
Major companies operating in the rat model market are Genoway SA, Charles River Laboratories International Inc, Taconic Biosciences Inc, Envigo Ltd, Janvier Labs, Harlan Laboratories Inc, Cyagen Biosciences Inc, Ozgene Pty Ltd, Beijing Biocytogen Co Ltd, Ingenious Targeting Laboratory, Mirimus Inc, Pharmaron Beijing Co Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Transgenic Inc, Viva Biotech Holdings, WuXi AppTec Co Ltd, Applied StemCell Inc, Transviragen Inc, Biomere, Laboratory Corporation of America Holdings, Horizon Discovery Group PLC, Synthego Corporation, ViGene Biosciences Inc.
North America was the largest region in the rat model market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rat model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the rat model market by increasing costs of imported genetic engineering tools, laboratory consumables, cryopreservation equipment, and specialized breeding materials. Research institutions in North America and Europe are most affected due to reliance on imported reagents and technologies, while Asia-Pacific faces higher costs in model export and collaboration. These tariffs are increasing research expenses and project timelines. However, they are also encouraging regional breeding facilities, local genetic testing capabilities, and domestic development of customized rat models.
The rat model market research report is one of a series of new reports that provides rat model market statistics, including rat model industry global market size, regional shares, competitors with a rat model market share, detailed rat model market segments, market trends and opportunities, and any further data you may need to thrive in the rat model industry. This rat model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The utilization of rat models involves leveraging rat functional genes, cells, tissues, and organs to simulate both healthy and pathological conditions of the human immune system. Humanized rat models play a crucial role in preclinical research, offering a means to replicate human disease states, assess the efficacy of compounds, and analyze their impact on human proteins.
Various types of rat models are available, including knockout, outbred, inbred, hybrid, immunodeficient, and conditioned models. In the context of knockout models, scientists modify or replace a gene to deactivate it, providing a valuable tool for studying the effects of specific gene alterations. Services provided encompass cryopreservation, breeding, re-derivation, genetic testing, and quarantine, utilizing technologies such as nuclear transferase, microinjection, and embryonic stem cells. These services cater to a range of applications, including oncology, neurology, immunology, toxicology, and more.
The rat model market includes revenues earned by entities by providing services such as DNA preparation, genotyping services, knock-in, or transgenic rat or mouse model creation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Rat Model Market Characteristics
3. Rat Model Market Supply Chain Analysis
4. Global Rat Model Market Trends and Strategies
5. Rat Model Market Analysis of End Use Industries
7. Global Rat Model Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Rat Model Total Addressable Market (TAM) Analysis for the Market
9. Rat Model Market Segmentation
10. Rat Model Market Regional and Country Analysis
11. Asia-Pacific Rat Model Market
12. China Rat Model Market
13. India Rat Model Market
14. Japan Rat Model Market
15. Australia Rat Model Market
16. Indonesia Rat Model Market
17. South Korea Rat Model Market
18. Taiwan Rat Model Market
19. South East Asia Rat Model Market
20. Western Europe Rat Model Market
21. UK Rat Model Market
22. Germany Rat Model Market
23. France Rat Model Market
24. Italy Rat Model Market
25. Spain Rat Model Market
26. Eastern Europe Rat Model Market
27. Russia Rat Model Market
28. North America Rat Model Market
29. USA Rat Model Market
30. Canada Rat Model Market
31. South America Rat Model Market
32. Brazil Rat Model Market
33. Middle East Rat Model Market
34. Africa Rat Model Market
36. Rat Model Market Competitive Landscape and Company Profiles
37. Rat Model Market Other Major and Innovative Companies
40. Rat Model Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Rat Model Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses rat model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rat model? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rat model market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Knockout; Outbred; Inbred; Hybrid; Immunodeficient; Conditioned2) By Service: Cryopreservation; Breeding; Re-derivation; Genetic Testing
3) By Application: Oncology; Neurology; Immunology; Toxicology; Other Applications
Subsegments:
1) By Knockout: CRISPR Knockout; Traditional Knockout2) By Outbred: Sprague Dawley; Long-Evans; Wistar
3) By Inbred: Fischer 344; Lewis; Buffalo
4) By Hybrid: F1 Hybrid; F2 Hybrid
5) By Immunodeficient: Nude Rats; SCID Rats
6) By Conditioned: Obese Rats; Diabetic Rats
Companies Mentioned: Genoway SA; Charles River Laboratories International Inc; Taconic Biosciences Inc; Envigo Ltd; Janvier Labs; Harlan Laboratories Inc; Cyagen Biosciences Inc; Ozgene Pty Ltd; Beijing Biocytogen Co Ltd; Ingenious Targeting Laboratory; Mirimus Inc; Pharmaron Beijing Co Ltd; PolyGene AG; Shanghai Model Organisms Center Inc; Transgenic Inc; Viva Biotech Holdings; WuXi AppTec Co Ltd; Applied StemCell Inc; Transviragen Inc; Biomere; Laboratory Corporation of America Holdings; Horizon Discovery Group PLC; Synthego Corporation; ViGene Biosciences Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Rat Model market report include:- Genoway SA
- Charles River Laboratories International Inc
- Taconic Biosciences Inc
- Envigo Ltd
- Janvier Labs
- Harlan Laboratories Inc
- Cyagen Biosciences Inc
- Ozgene Pty Ltd
- Beijing Biocytogen Co Ltd
- Ingenious Targeting Laboratory
- Mirimus Inc
- Pharmaron Beijing Co Ltd
- PolyGene AG
- Shanghai Model Organisms Center Inc
- Transgenic Inc
- Viva Biotech Holdings
- WuXi AppTec Co Ltd
- Applied StemCell Inc
- Transviragen Inc
- Biomere
- Laboratory Corporation of America Holdings
- Horizon Discovery Group PLC
- Synthego Corporation
- ViGene Biosciences Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.92 Billion |
| Forecasted Market Value ( USD | $ 2.8 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
